CN Stock MarketDetailed Quotes

000513 Livzon Pharmaceutical Group Inc.

Watchlist
  • 36.91
  • -0.19-0.51%
Market Closed Jan 3 15:00 CST
33.64BMarket Cap16.61P/E (TTM)

Livzon Pharmaceutical Group Inc. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Livzon Pharmaceutical Group Inc. Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 3.524B--
--2024/Q4-- / 2.774B--
--2024/Q32.799B / 3.252B--
--2024/Q23.040B / 3.207B--
--2024/Q13.243B / 3.357B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 3.524B--
--2024/Q4-- / 2.774B--
--2024/Q32.799B / 3.252B--
--2024/Q23.040B / 3.207B--
--2024/Q13.243B / 3.357B--

Unlock Free Earnings Estimates

Livzon Pharmaceutical Group Inc. Earnings Reports

  • Livingstone Group: Report for the third quarter of 2024

    Oct 24, 2024 00:00

  • Livzon Pharmaceutical Group Inc.: Half-year report for the year 2024.

    Aug 23, 2024 00:00

  • Livzon Pharmaceutical Group Inc.: Summary of Half-Year Report in 2024.

    Aug 23, 2024 00:00

  • Livingstone Group: Report for the first quarter of 2024

    Apr 24, 2024 00:00

    • Read more

    Top CN Stock Gainers
    Symbol Price % Chg
    Baotou Tianhe Magnetics Technology
    603072
    48.00 +290.24%
    HuangShan Googe
    301581
    70.01 +154.58%
    Geovis Insighter Technology
    920116
    45.63 +30.00%
    CHICHENG ELECTRIC
    834407
    23.69 +29.95%
    Xdc Industries(Shenzhen)Limited
    300615
    16.55 +20.01%

    See the daily top gainer.

    Analysis

    Analyst Rating

    Updated: Jan 4, 2025

    Strong Buy

    • Strong Buy

      84.62%

    • Buy

      15.39%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Investment Theme Virus Testing
    Virus Testing
    Intraday-0.31%
    Virus Prevention
    Virus Prevention
    Intraday-0.69%
    Monoclonal Antibody Concept
    Monoclonal Antibody Concept
    Intraday-0.75%